Average Co-Inventor Count = 7.00
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Biomarin Pharmaceutical Inc. (7 from 135 patents)
7 patents:
1. 11254725 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
2. 10301369 - Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins
3. 9845346 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
4. 9834587 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
5. 9834588 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
6. 9771408 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
7. 9376480 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof